Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China
Present at the 3rd Quality Science of Biologics Summit, 12-13 Aug. 2022, Beijing, China Gaithersburg, MD (11 Aug. 2022)...
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation from the FDA to IMM2902 for the treatment of HER-2+ breast cancer patients
As the project partner, BLA Regulatory congratulates ImmuneOnco for receiving Fast Track designation from the FDA to IMM2902 for the...
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA IND may proceed letter for BIO-106
As the regulatory consultant, Dr. Frank Li, congratulates BiOneCure Therapeutics on receiving US FDA IND may proceed letter for BIO-106...